LivaNova PLC

Healthcare · Medical Devices

77.20$ -1.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

LivaNova PLC (LIVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 2,606 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet LIVN
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	53	42	40	40	68	70	95	94	99	152	136	105	146	207	211	212	264	294	294	2,559	2,343	2,504	2,550	2,412	2,400	2,201	2,295	2,430	2,506	2,606
Current Assets	50	32	32	31	59	60	87	86	90	137	127	98	106	143	152	161	207	220	220	673	620	870	533	549	708	679	886	988	1,127	1,102
Cash	18	0.2	1.6	15	43	40	58	58	39	92	90	63	55	85	89	97	121	103	103	113	40	94	47	61	253	208	214	267	429	636
Cash & Short-Term Investments	18	0.2	21	16	43	40	58	58	61	92	90	63	55	85	89	97	136	128	128	120	40	94	47	61	253	208	214	267	429	636
Receivables	2.6	4.1	5.5	8.7	10.0	13	19	16	21	21	19	20	25	24	29	39	51	51	51	272	276	286	256	258	185	223	215	215	224	216
Inventory	1.2	4.5	5.2	5.0	3.7	5.9	6.7	7.8	8.5	17	15	12	14	16	15	14	18	18	18	212	184	145	154	164	115	106	129	148	148	165
Property, Plant & Equipment	–	–	–	–	8.7	9.8	9.6	8.3	8.9	10	8.0	5.5	5.6	7.5	8.2	22	29	40	40	245	204	192	191	236	164	191	183	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	745	745	745	692	784	957	916	922	900	769	783	750	793
Intangible Assets	–	–	–	–	–	–	–	–	–	–	–	–	–	4.8	5.2	4.5	9.2	12	12	659	609	535	770	608	438	400	369	261	237	230
Total Liabilities	3.8	5.2	6.4	13	25	27	28	25	23	148	151	90	47	34	36	28	34	35	35	747	636	689	1,046	1,028	1,291	906	1,087	1,152	1,186	1,406
Current Liabilities	3.7	5.3	6.3	12	25	27	28	25	23	147	142	17	18	27	29	23	29	30	30	359	317	406	497	513	309	697	297	335	392	808
Short-Term Debt	–	–	0.1	0.1	6.1	7.1	10	3.0	3.0	128	125	–	–	7.0	0.0	0.0	–	176	176	83	48	84	29	89	25	241	33	26	87	32
Accounts Payable	0.7	2.3	1.8	1.8	5.9	6.5	5.9	6.6	5.2	6.0	2.9	3.6	3.6	4.3	4.9	8.0	7.6	7.3	7.3	110	93	86	77	86	74	68	74	81	70	97
Long-Term Debt	–	–	–	–	0.4	0.3	0.1	–	–	–	–	125	62	15	–	–	–	94	94	92	75	62	140	260	642	9.8	518	569	550	345
Shareholders' Equity	49	37	33	27	43	43	67	69	76	4.6	-15	16	99	173	175	183	230	259	259	1,811	1,707	1,815	1,504	1,384	1,109	1,295	1,208	1,278	1,320	1,200
Retained Earnings	-57	-72	-76	-92	-123	-129	-117	-118	-130	-207	-272	-249	-176	-125	-117	-81	-35	20	20	48	-15	-40	-252	-407	-762	-898	-984	-966	-903	-1,146
Shares Outstanding	12	16	18	18	–	22	22	26	24	25	26	26	28	29	29	28	28	27	27	27	49	49	48	48	49	51	54	54	55	55

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings